Vitruvias Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 6

Vitruvias Therapeutics General Information

Description

Operator of a generic pharmaceutical company intended to develop complex APIs and finished dosage forms that are inherently difficult to manufacture. The company manufactures technically difficult generic products and overcomes the manufacturing complexities and raw material sourcing challenges by utilizing strategic partnerships in order to increase the availability of vital generic drugs.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 778 North Dean Road
  • Suite 600
  • Auburn, AL 36830
  • United States
+1 (334)
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Parent Company
Corporate Office
  • 778 North Dean Road
  • Suite 600
  • Auburn, AL 36830
  • United States
+1 (334)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vitruvias Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vitruvias Therapeutics‘s full profile, request access.

Request a free trial

Vitruvias Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a generic pharmaceutical company intended to develop complex APIs and finished dosage forms that are inheren
Pharmaceuticals
Auburn, AL
11 As of 2022

Mumbai, India
 

Hyderabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vitruvias Therapeutics Competitors (8)

One of Vitruvias Therapeutics’s 8 competitors is Cipla, a Corporation company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cipla Corporation Mumbai, India
Dr. Reddy's Corporation Hyderabad, India
Pfizer (Vienna) Corporation Vienna, Austria
GSK Corporation London, United Kingdom
Novartis Corporation Basel, Switzerland
You’re viewing 5 of 8 competitors. Get the full list »

Vitruvias Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vitruvias Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vitruvias Therapeutics‘s full profile, request access.

Request a free trial

Vitruvias Therapeutics FAQs

  • When was Vitruvias Therapeutics founded?

    Vitruvias Therapeutics was founded in 2013.

  • Where is Vitruvias Therapeutics headquartered?

    Vitruvias Therapeutics is headquartered in Auburn, AL.

  • What is the size of Vitruvias Therapeutics?

    Vitruvias Therapeutics has 11 total employees.

  • What industry is Vitruvias Therapeutics in?

    Vitruvias Therapeutics’s primary industry is Pharmaceuticals.

  • Is Vitruvias Therapeutics a private or public company?

    Vitruvias Therapeutics is a Private company.

  • What is Vitruvias Therapeutics’s current revenue?

    The current revenue for Vitruvias Therapeutics is .

  • How much funding has Vitruvias Therapeutics raised over time?

    Vitruvias Therapeutics has raised $15M.

  • Who are Vitruvias Therapeutics’s investors?

    JW Asset Management and Perceptive Advisors have invested in Vitruvias Therapeutics.

  • Who are Vitruvias Therapeutics’s competitors?

    Cipla, Dr. Reddy's, Pfizer (Vienna), GSK, and Novartis are some of the 8 competitors of Vitruvias Therapeutics.

  • When was Vitruvias Therapeutics acquired?

    Vitruvias Therapeutics was acquired on 06-Aug-2026.

  • Who acquired Vitruvias Therapeutics?

    Vitruvias Therapeutics was acquired by H2 Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process